
    
      It is a clinical, prospective, double-blind, randomized study. 114 women with gynecologic
      disease, in which there is indication of laparoscopic surgical approach, will be
      consecutively select. These women will be allocated in two arms, control and study, where
      control group will use placebo and study will receive intravenous cephazolin. These patients
      will be followed for 30 days according to Centers for Disease Control and Prevention
      criteria.
    
  